BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3020277)

  • 1. [A case of early uptake of hepatobiliary scan agent in hepatocellular carcinoma].
    Fujikawa M; Okazaki K; Miyao M; Miyazaki M; Onishi S; Ito K; Yoshida S; Nakasato J
    Rinsho Hoshasen; 1986 Jun; 31(6):749-52. PubMed ID: 3020277
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonvisualization of hepatoma with Tc-99m hepatobiliary agent.
    Lamki N; Raval B; Chamberlain M
    J Nucl Med; 1981 Mar; 22(3):293. PubMed ID: 6259304
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of 99m Tc-HIDA scintigraphy in liver cell carcinoma and its metastatic foci].
    Yasunaga T; Hirota Y; Ueno S; Tsuchigame T; Takahashi M; Beppu S
    Kaku Igaku; 1982 May; 19(4):523-8. PubMed ID: 6290722
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma: uptake of 99mTc-IDA in primary tumor and metastasis.
    Lee VW; O'Brien MJ; Devereux DF; Morris PM; Shapiro JH
    AJR Am J Roentgenol; 1984 Jul; 143(1):57-61. PubMed ID: 6328961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of hepatobiliary agents by hepatocellular carcinoma.
    Vincent LM; Renner JB
    AJR Am J Roentgenol; 1984 Nov; 143(5):1119-21. PubMed ID: 6091431
    [No Abstract]   [Full Text] [Related]  

  • 6. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma, adenoma, and focal nodular hyperplasia.
    Kotzerke J; Schwarzrock R; Krischek O; Wiese H; Hundeshagen H
    J Nucl Med; 1989 Jul; 30(7):1278-80. PubMed ID: 2544700
    [No Abstract]   [Full Text] [Related]  

  • 7. Tc-99m HIDA hepatobiliary agent in the diagnosis of pulmonary metastasis from hepatocellular carcinoma.
    Wang PW; Tai DI; Chen HY
    Clin Nucl Med; 1991 Feb; 16(2):120-3. PubMed ID: 1848494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrahepatic hepatocellular carcinoma metastasis demonstrated by technetium-99 HIDA scan.
    Bader TF
    Dig Dis Sci; 1988 Jan; 33(1):111-3. PubMed ID: 2827971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallium uptake by a rare primary hepatic malignancy.
    Lamki L; Holliday R
    Clin Nucl Med; 1983 Mar; 8(3):129-30. PubMed ID: 6303669
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic value of Tc-99m DEIDA in hepatocellular carcinoma.
    Tzen KY; Lee EF; How SW; Hsu JC
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):945-50. PubMed ID: 6292327
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamic hepatobiliary scan appearance of hepatocellular carcinoma.
    Intenzo CM; Hendricks P; Kim S; Park CH
    Clin Nucl Med; 1988 May; 13(5):325-6. PubMed ID: 2839314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatobiliary imaging of functional and morphological changes following hepatic arterial embolization in hepatocellular carcinoma.
    Tai DI; Chen HY; Wang PW; Lee CH; Lee TY; Chen WJ; Chen JJ; Chang Chien CS
    J Nucl Med; 1995 Sep; 36(9):1590-4. PubMed ID: 7658215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of Tc-99m di-isopropyliminodiacetic acid by hepatocellular carcinoma: concise communication.
    Savitch I; Kew MC; Paterson A; Esser JD; Levin J
    J Nucl Med; 1983 Dec; 24(12):1119-22. PubMed ID: 6315902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation.
    Calvet X; Pons F; Bruix J; Bru C; Lomeña F; Herranz R; Brugera M; Faus R; Rodes J
    J Nucl Med; 1988 Dec; 29(12):1916-20. PubMed ID: 2848112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphic detection of a metastasizing hepatocellular carcinoma].
    Heintz P; Gratz KF; Schwarzrock R; Schober O; Neuhaus P; Creutzig H
    Rofo; 1986 Jan; 144(1):111-3. PubMed ID: 3003828
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidental finding of a hepatic lesion: differential diagnostic problems for fibrolamellar hepatic carcinoma.
    Reuland P; Aicher KP; Brambs HJ; Enderle G; Feine U; Gärtner HV; Weber P
    J Nucl Med; 1994 Aug; 35(8):1342-6. PubMed ID: 8046491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma.
    Pons F; Lomeña F; Calvet X; Bruix J; Catafau A; Ginés A; Herranz R; Setoain J
    Clin Nucl Med; 1988 Apr; 13(4):280-2. PubMed ID: 2836119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of Tc-99m-PIPIDA in pulmonary metastases from a hepatoma.
    Cannon JR; Long RF; Berens SV; Caplan GE
    Clin Nucl Med; 1980 Jan; 5(1):22-4. PubMed ID: 6243523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical scintigraphic presentation of hepatocellular carcinoma.
    Cheng AE; Yee CA; Saul R
    Clin Nucl Med; 1994 Jun; 19(6):486-7. PubMed ID: 8062463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma.
    Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S
    Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.